+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Hepatitis Test Solution/Diagnosis Market by Technology (Chromatography, Immunoassay, Molecular Diagnostics), Product Type (Instruments, Kits & Reagents, Software & Services), End User, Test Type, Application - Global Forecast 2025-2030- Product Image
Hepatitis Test Solution/Diagnosis Market by Technology (Chromatography, Immunoassay, Molecular Diagnostics), Product Type (Instruments, Kits & Reagents, Software & Services), End User, Test Type, Application - Global Forecast 2025-2030- Product Image
Sale

Hepatitis Test Solution/Diagnosis Market by Technology (Chromatography, Immunoassay, Molecular Diagnostics), Product Type (Instruments, Kits & Reagents, Software & Services), End User, Test Type, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904514
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The hepatitis test solution/diagnosis market is evolving rapidly, shaped by advances in molecular diagnostics, the expansion of point-of-care technologies, and strategic supply chain adaptations. Senior decision-makers require actionable market intelligence to address emerging opportunities and competitive pressures as healthcare systems prioritize accessible, accurate hepatitis diagnostics.

Market Snapshot: Hepatitis Test Solution/Diagnosis Market Overview

The hepatitis test solution/diagnosis market grew from USD 3.71 billion in 2024 to USD 3.92 billion in 2025. The market is anticipated to sustain a CAGR of 5.57%, reaching USD 5.13 billion by 2030. Growth is underpinned by continuous advancements in diagnostic platforms, evolving clinical needs, and increasing global awareness around hepatitis screening and monitoring. Demand is driven by the integration of innovative testing solutions in both centralized and decentralized healthcare settings, coupled with expanded regulatory and collaborative frameworks that enhance global market reach.

Scope & Segmentation

This report delivers comprehensive analysis and forecasts by dissecting the hepatitis test solution/diagnosis market across strategic segments:

  • Technology: Covers chromatography (FIA, HPLC), immunoassay (chemiluminescent immunoassays, ELISA, rapid immunoassays), and molecular diagnostics (isothermal amplification, PCR, real-time PCR).
  • Product Type: Includes instruments (bench-top, high-throughput), kits & reagents (chromatography, immunoassay, molecular assay kits), and software & services supporting data and technical integration.
  • End User: Captures blood banks, clinics, diagnostic laboratories (hospital-based and independent), home care settings, and hospitals (general and specialized), addressing core market dynamics.
  • Test Type: Divides the landscape into confirmatory tests (ELISA confirmatory, PCR confirmatory) and initial screening tests.
  • Application: Incorporates both clinical diagnostics and research, recognizing the market’s dual focus on routine patient care and innovation.
  • Regional Coverage: Analyzes Americas (including specific US states, Canada, Mexico, Brazil, Argentina), EMEA (with a diverse range of European, Middle Eastern, and African markets), and Asia-Pacific (China, India, Japan, and key regional economies).
  • Company Analysis: Reviews competitive positioning and recent activity among leaders such as Abbott Laboratories, Beckman Coulter, Inc., F. Hoffmann-La Roche AG, bioMérieux SA, Cepheid, and others.

Key Takeaways for Strategy

  • Innovation in hepatitis testing is shifting toward integrated rapid immunoassays and molecular platforms, delivering improved clinical decision support and patient monitoring.
  • Expanded adoption of point-of-care solutions and decentralized testing is bridging gaps in resource-limited regions, enhancing screening and early intervention capabilities.
  • Automated platforms and AI-infused interpretation are empowering laboratories with robust, multidimensional datasets for genotype analysis and resistance prediction.
  • Collaborations between technology firms, public agencies, and healthcare providers are accelerating validation cycles and enabling faster regulatory approvals for new assays.
  • Strategic partnerships and acquisitions are reshaping market share, with bundled offerings and data integration solutions playing a key role in advancing provider loyalty and operational efficiency.
  • Flexible business models—such as reagent rental agreements—are supporting access and scalability for diagnostic laboratories of all sizes.

Tariff Impact on Hepatitis Testing Supply Chains

Recent United States tariff measures introduced in 2025 have increased costs for imported assay components, driving manufacturers to diversify sourcing and localize production. The localization trend is strengthening regional supply chain resilience, encouraging long-term agreements, and stabilizing operational budgets. Equipment vendors and diagnostic providers have responded by forging new supplier relationships and investing in domestic production to offset tariff exposure and support predictable, consistent access to critical testing supplies.

Primary Keyword: Hepatitis Test Solution/Diagnosis Market

Methodology & Data Sources

Findings draw from primary interviews with clinical, procurement, and public health leaders as well as secondary research of peer-reviewed literature and industry databases. Rigorous data triangulation ensures findings reflect both validated current practices and forward-looking trends.

Why This Report Matters

  • Delivers a segmented and regionalized perspective essential for identifying strategic market entry and growth opportunities.
  • Supports investment and procurement decisions by mapping technological innovation and collaborative industry shifts in hepatitis diagnostics.
  • Empowers senior leaders with credible, actionable insights to optimize portfolios and mitigate supply chain and regulatory risk.

Conclusion

Senior decision-makers will find this report a targeted resource for navigating acute shifts across the hepatitis test solution/diagnosis landscape. The insights enable effective strategy, informed investment, and sustainable market positioning as diagnostic paradigms continue to evolve.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of point-of-care NAT testing devices with cloud-based patient data management platforms for hepatitis diagnosis
5.2. Adoption of multiplexed rapid diagnostic test panels enabling simultaneous detection of hepatitis B, C and E antigens in resource-limited settings
5.3. Development of digital immunoassay platforms leveraging smartphone readouts for quantitative monitoring of hepatitis B surface antigen levels
5.4. Growing use of CRISPR-based molecular diagnostics for ultra-sensitive detection of hepatitis C viral RNA at the point of care
5.5. Rising investments in microfluidic lab-on-a-chip devices for portable, low-cost hepatitis serological testing in rural clinics
5.6. Expansion of hepatitis screening initiatives through at-home self-collection kits with telehealth integration for underserved populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Hepatitis Test Solution/Diagnosis Market, by Technology
8.1. Introduction
8.2. Chromatography
8.2.1. Fia
8.2.2. Hplc
8.3. Immunoassay
8.3.1. Chemiluminescent Immunoassays
8.3.2. Elisa
8.3.3. Rapid Immunoassays
8.4. Molecular Diagnostics
8.4.1. Isothermal Amplification
8.4.2. Pcr
8.4.3. Real-Time Pcr
9. Hepatitis Test Solution/Diagnosis Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Bench-Top Instruments
9.2.2. High-Throughput Instruments
9.3. Kits & Reagents
9.3.1. Chromatography Kits
9.3.2. Immunoassay Kits
9.3.3. Molecular Assay Kits
9.4. Software & Services
10. Hepatitis Test Solution/Diagnosis Market, by End User
10.1. Introduction
10.2. Blood Banks
10.3. Clinics
10.4. Diagnostic Laboratories
10.4.1. Hospital-Based Laboratories
10.4.2. Independent Laboratories
10.5. Home Care Settings
10.6. Hospitals
10.6.1. General Hospitals
10.6.2. Specialized Hospitals
11. Hepatitis Test Solution/Diagnosis Market, by Test Type
11.1. Introduction
11.2. Confirmatory Tests
11.2.1. Elisa Confirmatory
11.2.2. Pcr Confirmatory
11.3. Screening Tests
12. Hepatitis Test Solution/Diagnosis Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics
12.3. Research
13. Americas Hepatitis Test Solution/Diagnosis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Hepatitis Test Solution/Diagnosis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Hepatitis Test Solution/Diagnosis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. AbbVie Inc.
16.3.3. Avantor Inc.
16.3.4. Beckman Coulter, Inc.
16.3.5. Bio-Rad Laboratories Inc.
16.3.6. bioMérieux SA
16.3.7. Cepheid
16.3.8. Creative Diagnostics
16.3.9. DiaSorin S.p.A.
16.3.10. Epitope Diagnostics, Inc.
16.3.11. Everlywell, Inc.
16.3.12. F. Hoffmann-La Roche AG
16.3.13. FUJIREBIO Inc.
16.3.14. GenMark Diagnostics, Inc.
16.3.15. Grifols S.A.
16.3.16. Hologic, Inc.
16.3.17. Laboratory Corporation of America Holdings
16.3.18. MedMira Inc.
16.3.19. Merck & Co., Inc
16.3.20. Meridian Bioscience, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RESEARCHAI
FIGURE 26. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RESEARCHSTATISTICS
FIGURE 27. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RESEARCHCONTACTS
FIGURE 28. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY FIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RAPID IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BENCH-TOP INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HIGH-THROUGHPUT INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SPECIALIZED HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY ELISA CONFIRMATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PCR CONFIRMATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY SCREENING TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 159. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 162. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 163. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 164. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 165. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 170. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 171. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 172. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 173. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 176. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 177. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 180. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 181. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 182. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 183. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. CANADA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 190. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 191. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 207. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY KITS & REAGENTS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY CONFIRMATORY TESTS, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM HEPATITIS TEST SOLUTION/DIAGNOSIS MARKET SIZE, BY TE

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Avantor Inc.
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • bioMérieux SA
  • Cepheid
  • Creative Diagnostics
  • DiaSorin S.p.A.
  • Epitope Diagnostics, Inc.
  • Everlywell, Inc.
  • F. Hoffmann-La Roche AG
  • FUJIREBIO Inc.
  • GenMark Diagnostics, Inc.
  • Grifols S.A.
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • MedMira Inc.
  • Merck & Co., Inc
  • Meridian Bioscience, Inc.

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.13 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Hepatitis Diagnostic Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 110 Pages
  • Global
From
Hepatitis Test Solution/Diagnosis - Global Strategic Business Report - Product Image

Hepatitis Test Solution/Diagnosis - Global Strategic Business Report

  • Report
  • 275 Pages
  • Global
From
Hepatitis E Diagnostic Tests - Global Strategic Business Report - Product Image

Hepatitis E Diagnostic Tests - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Hepatitis C Testing Global Market Report 2025 - Product Image

Hepatitis C Testing Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Hepatitis Diagnostic Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Hepatitis Test Solution Diagnosis Market

In the realm of infectious disease testing, the hepatitis test solution diagnosis market comprises a segment focused on detecting and quantifying the presence of hepatitis infections, which include Hepatitis A, B, C, D, and E. Diagnosis of these conditions is critical due to their impact on liver function and potential for causing liver disease, cirrhosis, or carcinoma. The market includes a variety of testing modalities such as immunoassay-based tests, PCR-based tests, and point-of-care testing platforms. These diagnostic tools help in screening blood donations, monitoring the disease, and managing treatment regimens for infected patients. Advances in biotechnology have led to the development of more rapid and sensitive tests, facilitating early detection and improved patient outcomes. Numerous enterprises partake in the hepatitis test solution diagnosis market. Some notable companies include Abbott Laboratories, known for their range of immunoassays and laboratory equipment; Roche Diagnostics, offering advanced molecular assays; Siemens Healthineers, providing a comprehensive suite of diagnostic solutions; and QIAGEN, which supplies technologies for nucleic acid amplification testing. Additionally, Bio-Rad Laboratories and Beckman Coulter offer a variety of testing reagents and instruments that support hepatitis diagnosis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.